The independent design will require that participants be assigned to XXXX XXXXXXXXX, the XXXXXXX group or XXX XXXX XXXXX. XXXXXXXXXX XX XXX XXX groups will XX XXXX utilizing a XXXXXX XXXXXXXXXX method like QuickCals or XXXXXXXX XXXXXXXXXX. XXX XXXXX XXXX to XXXX XX men in XXX drug XXXXX and XX XXX in the placebo group. XXX would also XXXX the XXXX XX/XX division with the women to XXX two groups. During XXX experiment, XXXXXXX XXXXX be XXXXX in XXX participant’s XXXXXX system XXXX XXXX XXXXXX. XXXX XXXXXX XXXXXXXXXXX XX XXXX if the drug really XX having XXXX XXXX XX XXXXXX XX XXX participant’s immune XXXXXX (Cozby &XXX; XXXXX, XXXX).
XX XXX XXXXXXXX measures XXXXXX, you XXXX XXXX XXX XXXXXXXXXXXX in XXXX XXXXXXXXXX of the XXXXXXXXXX. This means XXXX you XXXXX first XXXX XXX XX of the participants in the drug XXXXX. XXXXX a XXXXXX XX time, you XXXXX then measure XXX XXXXXXX in XXX XXXXXXXXXXXX’ XXXXXX XXXXXX. XXXX you XXXXX XXXX XXX XX of XXX XXXXXXXXXXXX in the placebo group. It XX XXXXXXXXX that an extended XXXXXX XX time XXXXXXX XXX two XXXXXX XX XXXXXXXX XXX XXXXXXX of XXX XXXXX condition. XXXX after an XXXXXXXXXXX period of time you would measure XXX differences in the participants’ immune XXXXXX. XXXX XXXX allow XXXXXXXXXXX to better find any statistical differences between the XXX XXXXXX due to XXXXXX the XXXX XXXXXXXXXXXX in both XXXXXX.
XXXXXXXXX:
XXXXX, P., & Bates, S. (XXXX). XXXXXXX in XXXXXXXXXX XXXXXXXX (12th ed.). Retrieved from https://phoenix.vitalsource.XXX/#/books/XXXXXXXXXX/cfi/6/X!/4/4@0:0.